Market News

Breaking headlines and analysis across every asset class.

Earnings
AD HOC NEWS • Oct 1, 2026
Piper Sandler raises target for Alphabet C stock

Piper Sandler has increased its price target for Alphabet C stock from USD 395.00 to USD 400.00, maintaining an "Overweight" rating ahead of the company's Q3 2026 earnings report scheduled for October 27, 2026. This adjustment comes as Alphabet reported strong Q2 2026 revenue of USD 119.8 billion, a 24% increase year-over-year, driven largely by an 82% growth in Google Cloud revenue. Despite increased capital expenditures, the stock closed at EUR 308.73 on October 1, 2026, still below its 52-wee

Markets
Investing.com Canada • Oct 1, 2026
Form 4 Kayne Anderson BDC For: 1 October By Investing.com

This article from Investing.com reports on a Form 4 filing for Kayne Anderson BDC, dated October 1. The brief mention indicates a financial transaction or disclosure related to the company. The article provides no further details beyond the filing's existence and date.

Earnings
AD HOC NEWS • Oct 1, 2026
Zacks cuts Seagate stock from Strong Buy to Hold

Zacks Research downgraded Seagate Technology Holdings plc from "strong buy" to "hold" despite the company reporting strong fiscal Q4 2026 results with revenue of USD 3.63 billion and EPS of USD 5.71. The downgrade contrasts with the broader analyst consensus, which includes 22 buy ratings and an average target of USD 986.00, highlighting disagreement on Seagate's valuation after its recent earnings growth. Seagate's stock was trading at EUR 823.00, up 1.11 percent, with a market capitalization o

Earnings
AD HOC NEWS • Oct 1, 2026
D.R. Horton authorizes USD 5.00 billion buyback for D.R. Horton stock

D.R. Horton has authorized a new $5.00 billion share repurchase program, replacing a prior program with a remaining balance of $53.00 million. The company expects to repurchase at least $3.25 billion in common stock during fiscal year 2026. This announcement comes despite a recent price target cut by Keefe, Bruyette and Woods, though the company's third-quarter earnings exceeded analyst estimates.

Markets
Stock Titan • Oct 1, 2026
After selling 49,064 shares, a 10% holder proposes another Hinge Health (HNGE) share sale.

Insight Venture Partners (Delaware) X, L.P., a 10% stockholder in Hinge Health, Inc. (HNGE), has proposed selling 77,248 Class A shares valued at $7,570,304, with an approximate sale date of September 30, 2026. This notice follows recent sales by the same entity, including 49,064 Class A shares on August 10, 2026, for over $4.4 million. Raymond James & Associates, Inc. is identified as the broker for this proposed transaction.

Markets
Stock Titan • Oct 1, 2026
After six sales, a 10% holder proposes another share sale at Hinge Health (HNGE).

Insight Venture Partners X, L.P., a 10% stockholder of Hinge Health, Inc. (HNGE), has proposed to sell 486,991 Class A shares valued at approximately $47.7 million, with an approximate sale date of September 30, 2026. This proposed sale follows six previous sales by the same partnership within the past three months, totaling over 700,000 shares. The Form 144 filing provides details on the securities to be sold, the acquisition history, and the previous sales made by the insider.

Markets
Stock Titan • Oct 1, 2026
A 10% stockholder plans a Hinge Health (HNGE) share sale through Raymond James.

Insight Venture Partners (Cayman) X, L.P., a 10% stockholder in Hinge Health, Inc. (HNGE), plans to sell 399,338 Class A shares valued at approximately $39.1 million through Raymond James & Associates, Inc. The approximate sale date is September 30, 2026. This notice also details six prior Class A share sales by the same stockholder between July 7 and August 10, 2026.

Markets
Stock Titan • Oct 1, 2026
A fund reports 1.1M shares in i3 Verticals (IIIV), a passive position above 5%.

Forager Fund, L.P., along with its general partner Forager Capital Management, LLC, Edward Kissel, and Robert MacArthur, has reported a collective beneficial ownership of 1,106,474 shares of i3 Verticals, Inc. (IIIV) Class A common stock, representing a 6.1% passive stake. This ownership is based on 18,019,748 shares outstanding as of August 6, 2026. The filing indicates sole voting and dispositive power for the fund and its general partner, while Kissel and MacArthur share voting and dispositiv

Markets
Investing.com UK • Oct 1, 2026
Form 144 KESTRA MEDICAL TECHNOLOGIES For: 1 October By Investing.com

This article reports on the filing of Form 144 by Kestra Medical Technologies for October 1st. It briefly mentions the company's stock symbol KMTS and provides a snapshot of current stock market performance for major indices, commodities, bonds, and selected shares. The piece is part of a financial news compilation from Investing.com.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.